MedPath

Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance

Not Applicable
Not yet recruiting
Conditions
Mood Disturbance
Registration Number
NCT06531863
Lead Sponsor
Auburn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Adults age 18-50<br><br> - Depression score of >13/21 on the DASS-21 indicating moderate severity<br><br> - No change in medications or supplements over the past 3 months<br><br> - Can read and speak English<br><br>Exclusion Criteria:<br><br> - Currently consume curcumin or green tea daily<br><br> - Currently, pregnant, nursing, or trying to become pregnant<br><br> - Currently diagnosed with a perimenopausal disorder

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in total distress as measured via DASS-21 total score.;Changes in serum brain derived neurotrophic factor (BDNF).
Secondary Outcome Measures
NameTimeMethod
Changes in DASS-21 subscales (depression, anxiety, stress).;Changes in subjective sleep quality.;Changes in subjective physical activity.;Changes in diet quality.;Number of Participants who report daily adherence to supplementation intake;Changes in fasting alanine aminotransferase (ALT);Changes in fasting aspartate aminotransferase (AST)
© Copyright 2025. All Rights Reserved by MedPath